Aljubran, A. H., Almuhaideb, A., Raef, H., Almehaidib, A., Badran, A. A., Elshenawy, M. A., Alharbi, S., Dayis, S. (2026). Peptide receptor radionuclide therapy (Lu-177 PRRT) in neuroendocrine tumors (NET) over 16 years: Single institution experience.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.628